Elsbernd Brian bought CPRX
September 4, 2025 · Form 4 insider transaction
Elsbernd Brian bought 30,000 shares of Catalyst Pharmaceuticals Inc at $2.24 per share, a transaction worth $67.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$2.24
Total value
$67.2K
InsiderElsbernd Brian
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateSeptember 4, 2025
Filing dateSeptember 5, 2025
Shares owned after218,564
OwnershipDirect
10b5-1 planNo
AmendedNo